BR112017005762A2 - aprimoramentos na funcionalidade muscular de idosos do sexo masculino - Google Patents

aprimoramentos na funcionalidade muscular de idosos do sexo masculino

Info

Publication number
BR112017005762A2
BR112017005762A2 BR112017005762A BR112017005762A BR112017005762A2 BR 112017005762 A2 BR112017005762 A2 BR 112017005762A2 BR 112017005762 A BR112017005762 A BR 112017005762A BR 112017005762 A BR112017005762 A BR 112017005762A BR 112017005762 A2 BR112017005762 A2 BR 112017005762A2
Authority
BR
Brazil
Prior art keywords
muscle
male
functionality
muscle functionality
seniors
Prior art date
Application number
BR112017005762A
Other languages
English (en)
Other versions
BR112017005762B1 (pt
Inventor
Breuille Denis
Vinyes Pares Gerard
Moritani Toshio
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112017005762A2 publication Critical patent/BR112017005762A2/pt
Publication of BR112017005762B1 publication Critical patent/BR112017005762B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/385Concentrates of non-alcoholic beverages
    • A23L2/39Dry compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • A23L2/66Proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/185Vegetable proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/011Hydrolysed proteins; Derivatives thereof from plants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018Hydrolysed proteins; Derivatives thereof from animals from milk
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/02Antioxidant
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/12Replacer
    • A23V2200/13Protein replacer
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/316Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

a presente invenção refere-se a uma composição que compreende uma fonte de proteína e um antioxidante, opcionalmente em combinação com um ácido graxo ômega-3, que pode tratar ou prevenir a sarcopenia em idosos do sexo masculino, reduzir a perda da funcionalidade muscular (por exemplo, força muscular, velocidade de marcha, etc.) em idosos do sexo masculino, aumentar a funcionalidade muscular em idosos do sexo masculino e/ou melhorar a recuperação da funcionalidade muscular após atrofia muscular em idosos do sexo masculino.
BR112017005762-0A 2014-10-14 2015-10-09 Composição compreendendo uma fonte de proteína, e um antioxidante e seu uso BR112017005762B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462063752P 2014-10-14 2014-10-14
US62/063,752 2014-10-14
PCT/EP2015/073361 WO2016058919A1 (en) 2014-10-14 2015-10-09 Improvement in muscle functionality of elderly males

Publications (2)

Publication Number Publication Date
BR112017005762A2 true BR112017005762A2 (pt) 2017-12-12
BR112017005762B1 BR112017005762B1 (pt) 2021-10-05

Family

ID=54293237

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017005762-0A BR112017005762B1 (pt) 2014-10-14 2015-10-09 Composição compreendendo uma fonte de proteína, e um antioxidante e seu uso

Country Status (9)

Country Link
US (1) US20190111083A1 (pt)
EP (1) EP3206699B1 (pt)
JP (1) JP6826033B2 (pt)
CN (1) CN106793806A (pt)
AU (1) AU2015332935B2 (pt)
BR (1) BR112017005762B1 (pt)
CA (1) CA2963182C (pt)
ES (1) ES2960218T3 (pt)
WO (1) WO2016058919A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10744100B2 (en) 2015-11-17 2020-08-18 Societe Des Produits Nestle S.A. Compositions and methods using a polyphenol for musculoskeletal health
JP6859336B2 (ja) * 2015-11-17 2021-04-14 ソシエテ・デ・プロデュイ・ネスレ・エス・アー 骨格筋の健康のためポリフェノールを使用する組成物及び方法
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
JPWO2018164251A1 (ja) * 2017-03-10 2020-01-09 株式会社明治 体力向上用組成物
KR20200039748A (ko) 2017-08-14 2020-04-16 악셀라 헬스 인크. 간 질환 치료를 위한 아미노산 조성물
CN111132925B (zh) * 2017-08-16 2022-07-05 可口可乐公司 用于具有个性化水合物溶液的运动饮料的饮料分配系统
CN111315239A (zh) * 2017-11-21 2020-06-19 雀巢产品有限公司 针对肌肉质量和/或肌肉量使用橄榄苦苷或姜黄素的组合物和方法
EP3810123A1 (en) 2018-06-20 2021-04-28 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
MX2021000046A (es) 2018-07-06 2021-04-19 Coca Cola Co Red de dispensadores de bebidas y gestion de perfiles.
CN112888320A (zh) * 2018-11-05 2021-06-01 雀巢产品有限公司 使用姜黄素和ω-3脂肪酸的组合用于细胞能量的组合物和方法
CN109588709A (zh) * 2018-12-04 2019-04-09 沈阳师范大学 一种预防老年肌肉衰减的复合蛋白粉及制备方法
CN113367349B (zh) * 2020-02-25 2024-03-12 内蒙古蒙牛乳业(集团)股份有限公司 用于肌肉衰减综合征的组合物、其制备方法和用途
CN111972672A (zh) * 2020-08-25 2020-11-24 黑龙江省完达山乳业股份有限公司 一种具有增加肌肉功能的组合物及其应用
CN115461050B (zh) * 2020-09-11 2023-11-28 李宗谚 药学组合物及其于治疗肌少症的用途
CN115177000A (zh) * 2021-04-07 2022-10-14 陕西罗麻丹医药有限公司 一种改善老年肌少症的粉剂及其制备方法
CN117915788A (zh) 2021-08-06 2024-04-19 N·V·努特里奇亚 用于肌肉质量、力量和功能的营养组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7966922B2 (en) * 2007-05-24 2011-06-28 Lockheed Martin Corporation Electro-magnetic restraint
US7790688B2 (en) * 2008-01-11 2010-09-07 Healthspan Solutions, Llc Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly
WO2010143939A1 (en) * 2009-06-09 2010-12-16 N.V. Nutricia Nutrition for improving muscle strength in elderly
US20120195873A1 (en) * 2009-07-20 2012-08-02 Nestec S.A. Methods of attenuating the loss of functional status
EP2311486A1 (en) * 2009-10-07 2011-04-20 Nestec S.A. GLP-2 for use in intestine and muscle recovery
WO2011098449A1 (en) * 2010-02-10 2011-08-18 Novartis Ag Methods and compounds for muscle growth
CN103458891A (zh) * 2011-04-13 2013-12-18 味之素株式会社 营养组合物
MX2013012228A (es) * 2011-04-18 2013-12-06 Nestec Sa Composiciones nutricionales que tienen a-hica y metodos para utilizar las mismas.
EP2580967A1 (en) * 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
CA2909211C (en) * 2013-04-15 2021-06-22 Nestec S.A. Use of whey protein in combination with electrical muscle stimulation
US20140357576A1 (en) * 2013-05-31 2014-12-04 Nestec S.A. Methods for enhancement of muscle protein synthesis

Also Published As

Publication number Publication date
AU2015332935B2 (en) 2020-11-26
CN106793806A (zh) 2017-05-31
EP3206699A1 (en) 2017-08-23
WO2016058919A1 (en) 2016-04-21
CA2963182C (en) 2023-10-17
JP6826033B2 (ja) 2021-02-03
ES2960218T3 (es) 2024-03-01
EP3206699B1 (en) 2023-09-13
JP2017536336A (ja) 2017-12-07
AU2015332935A1 (en) 2017-03-09
CA2963182A1 (en) 2016-04-21
BR112017005762B1 (pt) 2021-10-05
US20190111083A1 (en) 2019-04-18

Similar Documents

Publication Publication Date Title
BR112017005762A2 (pt) aprimoramentos na funcionalidade muscular de idosos do sexo masculino
CO2017013443A2 (es) Composiciones que comprenden cepas bacterianas del género blautia
BR112018010211A2 (pt) formulação farmacêutica aquosa compreendendo anticorpo anti-pd-l1 avelumab
BR112019000338A2 (pt) composições compreendendo cepas bacterianas
CL2018001349A1 (es) Composiciones que comprenden cepas bacterianas
CL2018001367A1 (es) Composiciones que comprenden cepas bacterianas
CL2016000839A1 (es) Composiciones para modular la expresión de c9orf72.
BR112018003184A2 (pt) absorvente feminino com braçadeiras de barreira
BR112016023851A2 (pt) ?composição de revestimento de duas partes e método para revestir uma superfície?
CL2017001438A1 (es) Antagonistas de miostatina o activina para el tratamiento de sarcopenia
CL2016002971A1 (es) Combinación.
BR112017002370A2 (pt) indóis para uso na infecção pelo vírus da gripe
BR112017004524A2 (pt) pirrolopirimidinas para uso na infecção pelo vírus da gripe
BR112018007958A2 (pt) composições e métodos que usam um polifenol para a saúde musculoesquelética
BR112016022593A2 (pt) composições e métodos para modular a expressão do fator b do complemento
BR112018003780A2 (pt) composições que compreendem um composto de urolitina
BR112018003745A2 (pt) composições que compreendem um composto de urolitina
BR112017018620A2 (pt) método de administração de tradipitanto, e, tradipitanto.
BR112016023754A2 (pt) ?uso de lactobacillus paracasei para promover recuperação da diversidade da microbiota intestinal após disbiose?
MA43314A (fr) Vecteurs de grippe atténues utilisés pour la prophylaxie et/ou le traitement de maladies infectieuses ainsi que pour le traitement de maladies oncologiques
AR102085A1 (es) Composición nutricional para el entorno gastrointestinal para la provisión de un perfil metabólico y microbioma mejorados
BR112017025639A2 (pt) brinquedo de transformação
BR112017023636A2 (pt) suplemento dietético
BR112017026834A2 (pt) composição compreendendo vitaminas b e vitaminas c e seu uso
MX2016009992A (es) Materiales, dispositivos, sistemas y metodos para identificar la uretra femenina.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B25A Requested transfer of rights approved

Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH)

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09W Correction of the decision to grant [chapter 9.1.4 patent gazette]

Free format text: REFERENTE AO DESPACHO 9.1 NOTIFICADO NA RPI NO 2639, DE 03/08/2021

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/10/2015, OBSERVADAS AS CONDICOES LEGAIS.